Valeria Righi1,2, Melissa Starkey3,
Jianxin He3, George Dai2, Vitaliano Tugnoli4,
Laurence G. Rahme3, Ronald G. Tompkins5, Aria A. Tzika1,2
1Department of Surgery, NMR
Surgical Laboratory, MGH & Shriners Burn Institute, Harvard Medical
School, Boston, MA, United States; 2Department of Radiology,
Athinoula A. Martinos Center of Biomedical Imaging, Boston, MA, United
States; 3Department of Surgery, Molecular Surgery Laboratory, MGH
& Shriners Burn Institute, Harvard Medical School, Boston, MA, United
States; 4Departement of Biochemistry, University of Bologna,
Bologna, Italy; 5Department of Surgery, MGH & Shriners Burn
Institute, Harvard Medical School, Boston, MA, United States
We demonstrated the feasibility to monitor inhibition of infection in a clinically relevant mouse model of infection after burn. Our results show that our novel compound M50 attenuates the signals coming from macrophages that accumulate at the infection site and thus support the compounds anti-infective action. These results may have direct implications in the longitudinal monitoring of infection, and open perspectives for testing our novel anti-virulence compounds.